QA: Corcept Therapeutics INC in us_pharma/2016

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001088856_2017_Corcept_Therapeutics_INC.pdf

Logs

Graph

Absolute values for 0001088856, Corcept Therapeutics INC

  xvar xval
0 AssetsCurrent 65,689,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 205,000
3 remainder_Assets 2,859,000
4 LiabilitiesCurrent 27,374,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 334,179
8 SellingGeneralAndAdministrativeExpense 42,565,948
9 ResearchAndDevelopmentExpense 20,859,627
10 remainder_Expenses 3,941,112
11 remainder_Revenues 236,386,563
12 remainder_NetIncome 0
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 68,753,000
1 Liabilities 27,374,000
2 Expenses 67,700,866
3 Revenues 236,386,563
4 StockholdersEquity 41,379,000
5 NetIncome 168,685,697
6 ComprehensiveNetIncome 168,685,697
7 BaseVar 200,107,214
8 EconomicCapitalRatiobeforeLimitedLiability 5.39
9 EconomicCapitalRatio 5.52

Edgar->Model Mapping

Feature Distribution

Change over Time